FA
NVO

Fedenia Advisers’s Novo Nordisk NVO Stock Holding History

Fedenia Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.6K Buy
+96
New +$4.13K ﹤0.01% 396
2026
Q1 		– Sell
-4,101
Closed -$209K – 137
2025
Q4 		$209K Buy
4,101
+21
+0.5% +$1.07K 0.08% 151
2025
Q3 		$226K Buy
+4,080
New +$239K 0.09% 149
2025
Q1 		– Sell
-3,296
Closed -$284K – 319
2024
Q4 		$284K Buy
+3,296
New +$356K 0.17% 112

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Fedenia Advisers's NVO Position: Q2 2026 in Review

Fedenia Advisers opened a new position in Novo Nordisk (NVO) in Q2 2026: 96 shares worth $4.6K. The stake represents ﹤0.01% of the portfolio and ranks #396 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in NVO as recently as Q4 2025.

Fedenia Advisers first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. The position peaked at $284K in Q4 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Fedenia Advisers held 96 shares of Novo Nordisk worth $4.6K as of Q2 2026.
  • Novo Nordisk was a new Fedenia Advisers position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Fedenia Advisers's portfolio in Q2 2026, its #396 holding.
  • Fedenia Advisers first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
  • Fedenia Advisers's Novo Nordisk position peaked at $284K in Q4 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.